Inflammatory Subtypes in Asthma are Related to Airway Hyperresponsiveness to Mannitol and Exhaled NO

References

• Pavord I D, Brightling C E, Woltmann G, Wardlaw A J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet Jun 26, 1999; 353(9171)2213–2114
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord I D. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol May, 2007; 119(5)1043–1052, quiz 1053–1054
   PubMed Web of Science ®Google Scholar
• Green R H, Brightling C E, Bradding P. The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol Feb, 2007; 7(1)43–50, Review
   PubMedGoogle Scholar
• Berry M A, Shaw D E, Green R H, Brightling C E, Wardlaw A J, Pavord I D. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy Sep, 2005; 35(9)1175–1179
   PubMed Web of Science ®Google Scholar
• Simpson J L, Scott R, Boyle M J, Gibson P G. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology Jan, 2006; 11(1)54–61
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Brannan J D, Anderson S D, Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy Jan, 2008; 38(1)43–50
   PubMed Web of Science ®Google Scholar
• Bateman E D, Hurd S S, Barnes P J, Bousquet J, Drazen J M, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen S E, Pizzichini E, Sullivan S D, Wenzel S E, Zar H J. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J Jan, 2008; 31(1)143–178
   PubMed Web of Science ®Google Scholar
• ATS Workshop Proceedings. Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate: Executive Summary. Am J Respir Crit Care Med Apr 1, 2006; 173(7)811–813
   PubMedGoogle Scholar
• Miller M R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten C P, Gustafsson P, Jensen R, Johnson D C, MacIntyre N, McKay R, Navajas D, Pedersen O F, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J Aug, 2005; 26(2)319–338
   PubMed Web of Science ®Google Scholar
• Anderson S D, Brannan J, Spring J, Spalding N, Rodwell L T, Chan K, Gonda I, Walsh A, Clark A R. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med Sep, 1997; 156: 758–765, (3 Pt 1)
   PubMed Web of Science ®Google Scholar
• Brannan J D, Anderson S D, Perry C P, Freed-Martens R, Lassig A R, Charlton B; Aridol Study Group. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res Dec 9, 2005; 6: 144
   PubMed Web of Science ®Google Scholar
• Paggiaro P L, Chanez P, Holz O, Ind P W, Djukanovic R, Maestrelli P, Sterk P J. Sputum induction. Eur Respir J Suppl Sep, 2002; 37: 3s–8s
   PubMedGoogle Scholar
• Dreborg S. Skin tetst used in type I allergy testing (position paper). Allergy 1989; 44(suppl.10)22–30
   Google Scholar
• Pizzichini E, Pizzichini M M, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluidphase measurements. Am J Respir Crit Care Med 1996; 154: 308–317
   PubMed Web of Science ®Google Scholar
• Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori G B, Bianchi A, Michetti G. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med Sep, 2000; 162: 1172–1174, (3 Pt 1)
   PubMed Web of Science ®Google Scholar
• Hargreave F E. Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Curr Opin Allergy Clin Immunol Feb, 2007; 7(1)102–106, Review
   PubMedGoogle Scholar
• Chaudhuri R, Livingston E, McMahon A D, Lafferty J, Fraser I, Spears M, McSharry C P, Thomson N C. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med Jul 15, 2006; 174(2)127–133
   PubMed Web of Science ®Google Scholar
• ten Brinke A, van Dissel J T, Sterk P J, Zwinderman A H, Rabe K F, Bel E H. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol Mar, 2001; 107(3)449–454
   PubMed Web of Science ®Google Scholar
• Simpson J L, Powell H, Boyle M J, Scott R J, Gibson P G. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med Jan 15, 2008; 177(2)148–155
   PubMed Web of Science ®Google Scholar
• Simpson J L, Grissell T V, Douwes J, Scott R J, Boyle M J, Gibson P G. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax Mar, 2007; 62(3)211–218
   PubMed Web of Science ®Google Scholar
• Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol Jan, 2008; 121(1)5–10
   PubMed Web of Science ®Google Scholar
• Peden D B, Tucker K, Murphy P, Newlin-Clapp L, Boehlecke B, Hazucha M, Bromberg P, Reed W. Eosinophil influx to the nasal airway after local, low-level LPS challenge in humans. J Allergy Clin Immunol Aug, 1999; 104: 388–394, (2 Pt 1)
   PubMed Web of Science ®Google Scholar
• Koskela H O, Hyvarinen L, Brannan J D, Chan H K, Anderson S D. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest Oct, 2003; 124(4)1341–1349
   PubMed Web of Science ®Google Scholar
• Smith A D, Cowan J O, Brassett K P, Filsell S, McLachlan C, Monti-Sheehan G, Peter Herbison G, Robin Taylor D. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med Aug 15, 2005; 172(4)453–459
   PubMed Web of Science ®Google Scholar